Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders; Generalised anxiety disorder
- Focus Therapeutic Use
- 16 Mar 2012 Actual patient number (49) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.